These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 15100702

  • 1. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents.
    Ugale RR, Hirani K, Morelli M, Chopde CT.
    Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents.
    Marx CE, VanDoren MJ, Duncan GE, Lieberman JA, Morrow AL.
    Neuropsychopharmacology; 2003 Jan; 28(1):1-13. PubMed ID: 12496935
    [Abstract] [Full Text] [Related]

  • 3. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT, Deshpande LS, Chopde CT.
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
    Hirani K, Sharma AN, Jain NS, Ugale RR, Chopde CT.
    Psychopharmacology (Berl); 2005 Jul; 180(2):267-78. PubMed ID: 15719223
    [Abstract] [Full Text] [Related]

  • 5. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats.
    Ugale RR, Sharma AN, Kokare DM, Hirani K, Subhedar NK, Chopde CT.
    Brain Res; 2007 Dec 12; 1184():193-201. PubMed ID: 17950705
    [Abstract] [Full Text] [Related]

  • 6. Essentiality of central GABAergic neuroactive steroid allopregnanolone for anticonvulsant action of fluoxetine against pentylenetetrazole-induced seizures in mice.
    Ugale RR, Mittal N, Hirani K, Chopde CT.
    Brain Res; 2004 Oct 08; 1023(1):102-11. PubMed ID: 15364024
    [Abstract] [Full Text] [Related]

  • 7. Olanzapine counteracts stress-induced anxiety-like behavior in rats.
    Locchi F, Dall'olio R, Gandolfi O, Rimondini R.
    Neurosci Lett; 2008 Jun 20; 438(2):146-9. PubMed ID: 18455305
    [Abstract] [Full Text] [Related]

  • 8. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
    Qiao J, Zhang Q, Li M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():177-85. PubMed ID: 24140929
    [Abstract] [Full Text] [Related]

  • 9. Effects of acute or chronic administration of risperidone on motor and sexual behavior of male rats.
    Drago F, Contarino A, Marino R, Anzallo C, Valerio C, Rampello L, Raffaele R, Scapagnini U.
    Pharmacol Res; 1997 Jan 03; 35(1):17-25. PubMed ID: 9149311
    [Abstract] [Full Text] [Related]

  • 10. Neuropharmacological profile of a novel potential atypical antipsychotic drug Y-931 (8-fluoro-12-(4-methylpiperazin-1-yl)- 6H-[1]benzothieno[2,3-b][1,5] benzodiazepine maleate).
    Morimoto T, Hashimoto K, Yasumatsu H, Tanaka H, Fujimura M, Kuriyama M, Kimura K, Takehara S, Yamagami K.
    Neuropsychopharmacology; 2002 Apr 03; 26(4):456-67. PubMed ID: 11927170
    [Abstract] [Full Text] [Related]

  • 11. The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice.
    Reddy DS, Kulkarni SK.
    Psychopharmacology (Berl); 1998 Jun 03; 137(4):391-400. PubMed ID: 9676900
    [Abstract] [Full Text] [Related]

  • 12. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models.
    Pereira M, Siba IP, Chioca LR, Correia D, Vital MA, Pizzolatti MG, Santos AR, Andreatini R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug 15; 35(7):1636-44. PubMed ID: 21689712
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
    Li M, He W, Mead A.
    Behav Pharmacol; 2009 Feb 15; 20(1):84-98. PubMed ID: 19179852
    [Abstract] [Full Text] [Related]

  • 14. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.
    Hirani K, Khisti RT, Chopde CT.
    Neuropharmacology; 2002 Dec 15; 43(8):1339-50. PubMed ID: 12527484
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA, Awouters FH, Meert TF, Schellekens KH, Niemegeers CJ, Janssen PA.
    J Pharmacol Exp Ther; 1992 Jan 15; 260(1):146-59. PubMed ID: 1370538
    [Abstract] [Full Text] [Related]

  • 16. Time course of the antipsychotic effect and the underlying behavioral mechanisms.
    Li M, Fletcher PJ, Kapur S.
    Neuropsychopharmacology; 2007 Feb 15; 32(2):263-72. PubMed ID: 16738541
    [Abstract] [Full Text] [Related]

  • 17. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
    Ding X, Li X, Shu Q, Wu R, Hu G, Li M.
    Behav Brain Res; 2017 Jun 15; 328():186-194. PubMed ID: 28412306
    [Abstract] [Full Text] [Related]

  • 18. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW.
    J Pharmacol Exp Ther; 2007 Aug 15; 322(2):862-70. PubMed ID: 17519387
    [Abstract] [Full Text] [Related]

  • 19. Parametric studies of antipsychotic-induced sensitization in the conditioned avoidance response model: roles of number of drug exposure, drug dose, and test-retest interval.
    Swalve N, Li M.
    Behav Pharmacol; 2012 Aug 15; 23(4):380-91. PubMed ID: 22732209
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
    Jardemark K, Marcus MM, Malmerfelt A, Shahid M, Svensson TH.
    Psychopharmacology (Berl); 2012 May 15; 221(1):115-31. PubMed ID: 22068461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.